The global market for RNAi technology is estimated to be USD 8.7 billion in 2014 and is expected to reach USD21.9 billion by 2019, growing at a CAGR of 20.19%
RNA interference (RNAi) is a natural process of treating forms of cancer and other diseases by post-transcriptional silencing of genes by small fragments of the nucleic acid. However, the path of RNAi therapies to the clinic has been more like a roller-coaster ride. RNAi technology can be helpful in providing target specificity to the prot Plus
